Global Implantable Neurostimulators Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Implantable Neurostimulators Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

According to APO Research, The global Implantable Neurostimulators market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Implantable Neurostimulators include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences and ElectroCore Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Implantable Neurostimulators, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Implantable Neurostimulators, also provides the sales of main regions and countries. Of the upcoming market potential for Implantable Neurostimulators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Implantable Neurostimulators sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Implantable Neurostimulators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Implantable Neurostimulators sales, projected growth trends, production technology, application and end-user industry.

Implantable Neurostimulators segment by Company

Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO
Implantable Neurostimulators segment by Type

Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Implantable Neurostimulators segment by Application

Parkinson's Disease
Epilepsy
Pain
Others
Implantable Neurostimulators segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Neurostimulators market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Implantable Neurostimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Implantable Neurostimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Implantable Neurostimulators Market Size, 2019 VS 2023 VS 2030
1.3 Global Implantable Neurostimulators Market Size Estimates and Forecasts (2019-2030)
1.4 Global Implantable Neurostimulators Sales Estimates and Forecasts (2019-2030)
1.5 Global Implantable Neurostimulators Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Implantable Neurostimulators Market Dynamics
2.1 Implantable Neurostimulators Industry Trends
2.2 Implantable Neurostimulators Industry Drivers
2.3 Implantable Neurostimulators Industry Opportunities and Challenges
2.4 Implantable Neurostimulators Industry Restraints
3 Implantable Neurostimulators Market by Manufacturers
3.1 Global Implantable Neurostimulators Revenue by Manufacturers (2019-2024)
3.2 Global Implantable Neurostimulators Sales by Manufacturers (2019-2024)
3.3 Global Implantable Neurostimulators Average Sales Price by Manufacturers (2019-2024)
3.4 Global Implantable Neurostimulators Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Implantable Neurostimulators Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Implantable Neurostimulators Manufacturers, Product Type & Application
3.7 Global Implantable Neurostimulators Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Implantable Neurostimulators Market CR5 and HHI
3.8.2 Global Top 5 and 10 Implantable Neurostimulators Players Market Share by Revenue in 2023
3.8.3 2023 Implantable Neurostimulators Tier 1, Tier 2, and Tier 3
4 Implantable Neurostimulators Market by Type
4.1 Implantable Neurostimulators Type Introduction
4.1.1 Deep Brain Stimulators
4.1.2 Spinal Cord Stimulators
4.1.3 Vagal Nerve Stimulators
4.1.4 Sacral Nerve Stimulators
4.1.5 Gastric Stimulators
4.1.6 Others
4.2 Global Implantable Neurostimulators Sales by Type
4.2.1 Global Implantable Neurostimulators Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Implantable Neurostimulators Sales by Type (2019-2030)
4.2.3 Global Implantable Neurostimulators Sales Market Share by Type (2019-2030)
4.3 Global Implantable Neurostimulators Revenue by Type
4.3.1 Global Implantable Neurostimulators Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Implantable Neurostimulators Revenue by Type (2019-2030)
4.3.3 Global Implantable Neurostimulators Revenue Market Share by Type (2019-2030)
5 Implantable Neurostimulators Market by Application
5.1 Implantable Neurostimulators Application Introduction
5.1.1 Parkinson's Disease
5.1.2 Epilepsy
5.1.3 Pain
5.1.4 Others
5.2 Global Implantable Neurostimulators Sales by Application
5.2.1 Global Implantable Neurostimulators Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Implantable Neurostimulators Sales by Application (2019-2030)
5.2.3 Global Implantable Neurostimulators Sales Market Share by Application (2019-2030)
5.3 Global Implantable Neurostimulators Revenue by Application
5.3.1 Global Implantable Neurostimulators Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Implantable Neurostimulators Revenue by Application (2019-2030)
5.3.3 Global Implantable Neurostimulators Revenue Market Share by Application (2019-2030)
6 Global Implantable Neurostimulators Sales by Region
6.1 Global Implantable Neurostimulators Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Implantable Neurostimulators Sales by Region (2019-2030)
6.2.1 Global Implantable Neurostimulators Sales by Region (2019-2024)
6.2.2 Global Implantable Neurostimulators Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Implantable Neurostimulators Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Implantable Neurostimulators Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Implantable Neurostimulators Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Implantable Neurostimulators Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Implantable Neurostimulators Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Implantable Neurostimulators Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Implantable Neurostimulators Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Implantable Neurostimulators Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Implantable Neurostimulators Revenue by Region
7.1 Global Implantable Neurostimulators Revenue by Region
7.1.1 Global Implantable Neurostimulators Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Implantable Neurostimulators Revenue by Region (2019-2024)
7.1.3 Global Implantable Neurostimulators Revenue by Region (2025-2030)
7.1.4 Global Implantable Neurostimulators Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Implantable Neurostimulators Revenue (2019-2030)
7.2.2 North America Implantable Neurostimulators Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Implantable Neurostimulators Revenue (2019-2030)
7.3.2 Europe Implantable Neurostimulators Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Implantable Neurostimulators Revenue (2019-2030)
7.4.2 Asia-Pacific Implantable Neurostimulators Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Implantable Neurostimulators Revenue (2019-2030)
7.5.2 LAMEA Implantable Neurostimulators Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Medtronic
8.1.1 Medtronic Comapny Information
8.1.2 Medtronic Business Overview
8.1.3 Medtronic Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Medtronic Implantable Neurostimulators Product Portfolio
8.1.5 Medtronic Recent Developments
8.2 Boston Scientific
8.2.1 Boston Scientific Comapny Information
8.2.2 Boston Scientific Business Overview
8.2.3 Boston Scientific Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
8.2.5 Boston Scientific Recent Developments
8.3 St. Jude Medical
8.3.1 St. Jude Medical Comapny Information
8.3.2 St. Jude Medical Business Overview
8.3.3 St. Jude Medical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 St. Jude Medical Implantable Neurostimulators Product Portfolio
8.3.5 St. Jude Medical Recent Developments
8.4 Cyberonics
8.4.1 Cyberonics Comapny Information
8.4.2 Cyberonics Business Overview
8.4.3 Cyberonics Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Cyberonics Implantable Neurostimulators Product Portfolio
8.4.5 Cyberonics Recent Developments
8.5 NeuroPace
8.5.1 NeuroPace Comapny Information
8.5.2 NeuroPace Business Overview
8.5.3 NeuroPace Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 NeuroPace Implantable Neurostimulators Product Portfolio
8.5.5 NeuroPace Recent Developments
8.6 Synapse Biomedical
8.6.1 Synapse Biomedical Comapny Information
8.6.2 Synapse Biomedical Business Overview
8.6.3 Synapse Biomedical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Synapse Biomedical Implantable Neurostimulators Product Portfolio
8.6.5 Synapse Biomedical Recent Developments
8.7 NeuroSigma
8.7.1 NeuroSigma Comapny Information
8.7.2 NeuroSigma Business Overview
8.7.3 NeuroSigma Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 NeuroSigma Implantable Neurostimulators Product Portfolio
8.7.5 NeuroSigma Recent Developments
8.8 ReShape Lifesciences
8.8.1 ReShape Lifesciences Comapny Information
8.8.2 ReShape Lifesciences Business Overview
8.8.3 ReShape Lifesciences Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 ReShape Lifesciences Implantable Neurostimulators Product Portfolio
8.8.5 ReShape Lifesciences Recent Developments
8.9 ElectroCore Medical
8.9.1 ElectroCore Medical Comapny Information
8.9.2 ElectroCore Medical Business Overview
8.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 ElectroCore Medical Implantable Neurostimulators Product Portfolio
8.9.5 ElectroCore Medical Recent Developments
8.10 Inspire Medical
8.10.1 Inspire Medical Comapny Information
8.10.2 Inspire Medical Business Overview
8.10.3 Inspire Medical Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Inspire Medical Implantable Neurostimulators Product Portfolio
8.10.5 Inspire Medical Recent Developments
8.11 NEUROS
8.11.1 NEUROS Comapny Information
8.11.2 NEUROS Business Overview
8.11.3 NEUROS Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 NEUROS Implantable Neurostimulators Product Portfolio
8.11.5 NEUROS Recent Developments
8.12 SPR
8.12.1 SPR Comapny Information
8.12.2 SPR Business Overview
8.12.3 SPR Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 SPR Implantable Neurostimulators Product Portfolio
8.12.5 SPR Recent Developments
8.13 IMTHERA
8.13.1 IMTHERA Comapny Information
8.13.2 IMTHERA Business Overview
8.13.3 IMTHERA Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 IMTHERA Implantable Neurostimulators Product Portfolio
8.13.5 IMTHERA Recent Developments
8.14 NEVRO
8.14.1 NEVRO Comapny Information
8.14.2 NEVRO Business Overview
8.14.3 NEVRO Implantable Neurostimulators Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 NEVRO Implantable Neurostimulators Product Portfolio
8.14.5 NEVRO Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Implantable Neurostimulators Value Chain Analysis
9.1.1 Implantable Neurostimulators Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Implantable Neurostimulators Production Mode & Process
9.2 Implantable Neurostimulators Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Implantable Neurostimulators Distributors
9.2.3 Implantable Neurostimulators Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings